Lyell Immunopharma (LYEL) Ownership - Who Owns Lyell Immunopharma?

159 Followers

Lyell Immunopharma (LYEL) Ownership Overview

47.36% Insiders

7.20% Mutual Funds

0.05% Other Institutional Investors

3.97% ETFs

41.42% Public Companies and

Individual Investors

The ownership structure of Lyell Immunopharma (LYEL) stock is a mix of institutional, retail, and individual investors. Approximately 11.22% of the company’s stock is owned by Institutional Investors, 47.36% is owned by Insiders, and 41.42% is owned by Public Companies and Individual Investors.

The ownership structure of Lyell Immunopharma (LYEL) stock is a mix of institutional, retail, and individual investors. Approximately 7.24% of the company’s stock is owned by Institutional Investors, 47.36% is owned by Insiders, and 3.97% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Mar 09, 2026	Arch Venture Partners Ix, Llc	xxxxxxxxxxxxx	$12499985
Mar 09, 2026	Arch Venture Fund Xiii, L.p.	xxxxxxxxxxxxx	$12499985
Feb 12, 2026	Lynn Seely	xxxxxxxxxxxxx	$174372
Feb 12, 2026	Hill Stephen J.	xxxxxxxxxxxxx	$28910

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	3,811,199	Insider	16.34%	81,902,667
	3,247,162	Insider	13.92%	69,781,511
	3,247,162	Insider	13.92%	69,781,511
	722,612	Institution	3.10%	15,528,932
	692,551	Institution	2.97%	14,882,921
	648,410	Institution	2.78%	13,934,331
	336,370	Insider	1.44%	7,228,591
	200,000	Insider	0.86%	4,298,000
	134,013	Institution	0.57%	2,879,939
Michael Rockefeller	98,425	Institution	0.42%	2,115,153

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
692,551	Institution	2.97%	14,882,921
648,410	Institution	2.78%	13,934,331
134,013	Institution	0.57%	2,879,939
71,141	Institution	0.30%	1,528,820
23,103	Institution	0.10%	496,483
21,220	Institution	0.09%	456,018
18,000	Institution	0.08%	386,820
14,149	Institution	0.06%	304,062
9,635	Institution	0.04%	207,056
9,320	Institution	0.04%	200,287

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	537,261	Institution	2.30%	10,777,456
Vanguard Extended Market ETF	162,336	Institution	0.70%	3,256,460
Schwab U.S. Small-Cap ETF	68,703	Institution	0.29%	1,476,427
iShares Biotechnology ETF	53,843	Institution	0.23%	1,157,086
Loncar China BioPharma ETF	30,080	Institution	0.13%	46,624
Vanguard Health Care ETF	23,015	Institution	0.10%	461,681
Avantis U.S Small Cap Equity ETF	17,632	Institution	0.08%	378,912
iShares NASDAQ US Biotechnology UCITS ETF	14,859	Institution	0.06%	336,111
Dimensional U.S. Small Cap ETF	12,766	Institution	0.05%	288,767
Schwab U.S. Broad Market ETF	9,101	Institution	0.04%	195,580

FAQ

Who Owns Lyell Immunopharma (LYEL)?

According to the latest TipRanks data, approximately 0.05% of the company's stock is held by institutional investors, 47.36% is held by insiders, and 41.42% is held by retail investors.

What percentage of Lyell Immunopharma (LYEL) stock is held by institutional investors?

According to the latest TipRanks data, approximately 0.05% of Lyell Immunopharma (LYEL) stock is held by institutional investors.

What percentage of Lyell Immunopharma (LYEL) stock is held by retail investors?

According to the latest TipRanks data, approximately 41.42% of Lyell Immunopharma (LYEL) stock is held by retail investors.

Who owns the most shares of Lyell Immunopharma (LYEL)?

Richard Klausner owns the most shares of Lyell Immunopharma (LYEL).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.